by Michael A. Moskowitz, M.D.
Migraine is not a fatal disorder but can ruin a life and a
family. Clinically migraine varies from patient to patient and reflects a
highly choreographed interplay between brain and the environment. Here is
the latest on what now is understood about migraine and what are becoming
effective drug targets for treatment. One of our series of Reports on Progress.by Kayt Sukel
Researchers describe sequence from distractibility to anxiety to inflammation to diabetes.by Moheb Costandi
Researchers at the 10th FENS Forum of Neuroscience in Copenhagen suggested that differences in sleep waves could reflect intelligence or disease states.by Brenda Patoine
We speak with Dana grantee Amit Etkin, whose lab is
investigating the use of repetitive transcranial magnetic stimulation in
combination with whole-brain EEG and functional MRI to treat depression
and help unravel its underlying brain circuitry. One of our series of Scientist Q & As.by Kayt Sukel
by Guy McKhann, MD
The World Health Organization estimates that 55 percent of
individuals in developed countries like the U.S. are not getting the mental health treatment
they require. Can mental health apps help fill the void for those who
lack access to in-person care? One of our series of Briefing Papers.
French neurosurgeon Alim-Louis Benabid may not have been the likeliest candidate to come up with a novel use for deep brain stimulation, but his pioneering method helped treat Parkinson's disease. Our monthly column from Brain in the News.